MARKET

VRTX

VRTX

Vertex Pharmaceuticals Inc
NASDAQ
422.00
+5.04
+1.21%
After Hours: 421.94 -0.06 -0.01% 16:55 01/17 EST
OPEN
422.73
PREV CLOSE
416.96
HIGH
428.25
LOW
419.27
VOLUME
1.77M
TURNOVER
--
52 WEEK HIGH
519.88
52 WEEK LOW
377.85
MARKET CAP
108.68B
P/E (TTM)
-211.8687
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VRTX last week (0113-0117)?
Weekly Report · 6h ago
3 Unstoppable Stocks to Buy in 2025
The Motley Fool · 2d ago
Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know
NASDAQ · 3d ago
HHS Challenges Vertex Over Fertility Services Program Tied To Casgevy Gene Therapy, Says Company Is 'Grasping at Straws'
Benzinga · 3d ago
Bank of America Securities Reaffirms Their Buy Rating on Vertex Pharmaceuticals (VRTX)
TipRanks · 4d ago
Next Century Growth Investors Q4 2024 Commentary
Seeking Alpha · 4d ago
Should You Buy Vertex Pharmaceuticals Stock Hand Over Fist Before Jan. 30?
The Motley Fool · 4d ago
CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers
Seeking Alpha · 4d ago
More
About VRTX
Vertex Pharmaceuticals Incorporated is a global biotechnology company. The Company is focused on investing in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has four approved medicines that treat the underlying cause of cystic fibrosis (CF), and one approved therapy that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT). Its pipeline includes clinical-stage programs in CF, SCD, TDT, acute and neuropathic pain, APOL1-mediated kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency. Its marketed medicines are TRIKAFTA/KAFTRIO, SYMDEKO/SYMKEVI (tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor) and KALYDECO (ivacaftor). It is developing non-autologous (allogeneic) fully differentiated, stem-cell derived islet cell therapies designed to replace insulin-producing islet cells that are destroyed in people with T1D.

Webull offers Vertex Pharmaceuticals Inc stock information, including NASDAQ: VRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRTX stock methods without spending real money on the virtual paper trading platform.